Eberhard L Renner
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Helbling B, Renner E, Meyer-Wyss B, Esteban A, Mullhaupt B, Dinges S, Wilhelmi M, Gonvers J, Borovicka J, Cerny A, Knöpfli M, Stamenic I, Jochum W, Swiss Association for the Study of the Liver (SASL). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis 2006; 13:762-9.
Nov 1, 2006HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Nov 1, 2006Journal of viral hepatitis 2006; 13:762-9
Helbling Beat, Renner Eberhard L, Meyer-Wyss Beat, Esteban Alicia, Mullhaupt Beat, Dinges Sabine, Wilhelmi Martin, Gonvers Jean-Jacques, Borovicka Jan, Cerny Andreas, Knöpfli Marina, Stamenic Ivan, Jochum Wolfram, Swiss Association for the Study of the Liver (SASL)
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
August-Jörg B, Renner E, Weitz M, Meyenberger C, Hermann R, Henz S, Gonvers J, Dufour J, Borovicka J, Swiss Association for the Study of the Liver. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60.
Aug 23, 2003Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
Aug 23, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60
August-Jörg Barbara S E, Renner Eberhard L, Weitz Manfred, Meyenberger Christa, Hermann Rudolf, Henz Samuel, Gonvers Jean-Jacques, Dufour Jean-François, Borovicka Jan, Swiss Association for the Study of the Liver
Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters
Fehr T, Riehle H, Nigg L, Grüter E, Ammann P, Renner E, Ambühl P. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters. American journal of kidney diseases : the official journal of the National Kidney Foundation 2003; 42:193-201.
Jul 1, 2003Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters
Jul 1, 2003American journal of kidney diseases : the official journal of the National Kidney Foundation 2003; 42:193-201
Fehr Thomas, Riehle Hans-Martin, Nigg Luzia, Grüter Erwin, Ammann Peter, Renner Eberhard L, Ambühl Patrice M
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Helbling B, Renner E, Sagmeister M, Borovicka J, Steuerwald M, Cathomas G, Reichen J, Dufour J, Gonvers J, Viani F, Stamenic I, Investigators of the Swiss Association for the Study of the Liver. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.) 2002; 35:447-54.
Feb 1, 2002Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Feb 1, 2002Hepatology (Baltimore, Md.) 2002; 35:447-54
Helbling Beat, Renner Eberhard L, Sagmeister Markus, Borovicka Jan, Steuerwald Michael, Cathomas Gieri, Reichen Jurg, Dufour Jean-François, Gonvers Jean-Jacques, Viani Francesco, Stamenic Ivan, Investigators of the Swiss Association for the Study of the Liver